CN113135869B - Method for preparing alpha-aryl carbonyl compound and product - Google Patents
Method for preparing alpha-aryl carbonyl compound and product Download PDFInfo
- Publication number
- CN113135869B CN113135869B CN202010062704.7A CN202010062704A CN113135869B CN 113135869 B CN113135869 B CN 113135869B CN 202010062704 A CN202010062704 A CN 202010062704A CN 113135869 B CN113135869 B CN 113135869B
- Authority
- CN
- China
- Prior art keywords
- compound
- substituted
- alkyl
- reaction
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 30
- -1 iodobenzene diacetate compound Chemical class 0.000 claims abstract description 39
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 16
- 150000002367 halogens Chemical class 0.000 claims abstract description 16
- 125000001424 substituent group Chemical group 0.000 claims abstract description 11
- 239000002841 Lewis acid Substances 0.000 claims abstract description 9
- 150000007517 lewis acids Chemical class 0.000 claims abstract description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 23
- 150000001875 compounds Chemical class 0.000 claims description 21
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 239000002585 base Substances 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 claims description 4
- XEFCWBLINXJUIV-UHFFFAOYSA-N acetic acid;iodobenzene Chemical class CC(O)=O.CC(O)=O.IC1=CC=CC=C1 XEFCWBLINXJUIV-UHFFFAOYSA-N 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 125000005936 piperidyl group Chemical group 0.000 claims description 3
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 claims description 3
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- LHJCZOXMCGQVDQ-UHFFFAOYSA-N tri(propan-2-yl)silyl trifluoromethanesulfonate Chemical compound CC(C)[Si](C(C)C)(C(C)C)OS(=O)(=O)C(F)(F)F LHJCZOXMCGQVDQ-UHFFFAOYSA-N 0.000 claims description 2
- STMPXDBGVJZCEX-UHFFFAOYSA-N triethylsilyl trifluoromethanesulfonate Chemical compound CC[Si](CC)(CC)OS(=O)(=O)C(F)(F)F STMPXDBGVJZCEX-UHFFFAOYSA-N 0.000 claims description 2
- 125000003504 2-oxazolinyl group Chemical class O1C(=NCC1)* 0.000 claims 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 abstract description 8
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract description 8
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract description 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract description 5
- 125000004093 cyano group Chemical group *C#N 0.000 abstract description 5
- 125000003545 alkoxy group Chemical group 0.000 abstract description 4
- 125000003118 aryl group Chemical group 0.000 abstract description 4
- 125000004104 aryloxy group Chemical group 0.000 abstract description 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract description 4
- 125000001188 haloalkyl group Chemical group 0.000 abstract description 4
- 125000000547 substituted alkyl group Chemical group 0.000 abstract description 4
- 239000003513 alkali Substances 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 3
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 48
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 20
- 238000005160 1H NMR spectroscopy Methods 0.000 description 14
- 239000007788 liquid Substances 0.000 description 11
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 10
- 235000019439 ethyl acetate Nutrition 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- ZBIKORITPGTTGI-UHFFFAOYSA-N [acetyloxy(phenyl)-$l^{3}-iodanyl] acetate Chemical compound CC(=O)OI(OC(C)=O)C1=CC=CC=C1 ZBIKORITPGTTGI-UHFFFAOYSA-N 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 150000002918 oxazolines Chemical class 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 4
- 239000007832 Na2SO4 Substances 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 238000006462 rearrangement reaction Methods 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- QOLHWXNSCZGWHK-BWBORTOCSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,7-dihydroxy-6-(11-phenoxyundecylcarbamoyloxy)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@@H]([C@@H](OC(=O)NCCCCCCCCCCCOC=3C=CC=CC=3)C(O1)(C(O)=O)C(O)(C(O2)C(O)=O)C(O)=O)O)C1=CC=CC=C1 QOLHWXNSCZGWHK-BWBORTOCSA-N 0.000 description 3
- OEENXWLHBPUUFL-UHFFFAOYSA-N 2-pentyl-4,5-dihydro-1,3-oxazole Chemical compound CCCCCC1=NCCO1 OEENXWLHBPUUFL-UHFFFAOYSA-N 0.000 description 3
- 229940126559 Compound 4e Drugs 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KXVKWZFUSKQARU-UHFFFAOYSA-N CC(C)CCCC1=NCCO1 Chemical compound CC(C)CCCC1=NCCO1 KXVKWZFUSKQARU-UHFFFAOYSA-N 0.000 description 2
- YXXNEKREPCFWFS-UHFFFAOYSA-N N-(2-chloroethyl)hexanamide Chemical compound CCCCCC(=O)NCCCl YXXNEKREPCFWFS-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 229960004365 benzoic acid Drugs 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- VIMMECPCYZXUCI-MIMFYIINSA-N (4s,6r)-6-[(1e)-4,4-bis(4-fluorophenyl)-3-(1-methyltetrazol-5-yl)buta-1,3-dienyl]-4-hydroxyoxan-2-one Chemical compound CN1N=NN=C1C(\C=C\[C@@H]1OC(=O)C[C@@H](O)C1)=C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 VIMMECPCYZXUCI-MIMFYIINSA-N 0.000 description 1
- YXZFFTJAHVMMLF-UHFFFAOYSA-N 1-bromo-3-methylbutane Chemical compound CC(C)CCBr YXZFFTJAHVMMLF-UHFFFAOYSA-N 0.000 description 1
- GUXJXWKCUUWCLX-UHFFFAOYSA-N 2-methyl-2-oxazoline Chemical compound CC1=NCCO1 GUXJXWKCUUWCLX-UHFFFAOYSA-N 0.000 description 1
- SAFZQLDSMLNONX-UHFFFAOYSA-N 2-phenoxyethenylbenzene Chemical group C=1C=CC=CC=1OC=CC1=CC=CC=C1 SAFZQLDSMLNONX-UHFFFAOYSA-N 0.000 description 1
- WSNKEJIFARPOSQ-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-(1-benzothiophen-2-ylmethyl)benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCC2=CC3=C(S2)C=CC=C3)C=CC=1 WSNKEJIFARPOSQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WRCUVAKWABKCNE-UHFFFAOYSA-N CC(C1=NCCO1)C(C=CC=C1)=C1I Chemical compound CC(C1=NCCO1)C(C=CC=C1)=C1I WRCUVAKWABKCNE-UHFFFAOYSA-N 0.000 description 1
- FILQAEDOGKFZNM-UHFFFAOYSA-N COCCCCCCCC1=NCCO1 Chemical compound COCCCCCCCC1=NCCO1 FILQAEDOGKFZNM-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- UPPGAVXYIVUREZ-UHFFFAOYSA-N O1C(=NCC1)C1=C(C=CC=C1)I Chemical compound O1C(=NCC1)C1=C(C=CC=C1)I UPPGAVXYIVUREZ-UHFFFAOYSA-N 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 125000005361 aryl sulfoxide group Chemical group 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 125000005520 diaryliodonium group Chemical group 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- YWGHUJQYGPDNKT-UHFFFAOYSA-N hexanoyl chloride Chemical compound CCCCCC(Cl)=O YWGHUJQYGPDNKT-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- YHBXLSOKBAEPMQ-UHFFFAOYSA-N n,2-dichloroethanamine Chemical compound ClCCNCl YHBXLSOKBAEPMQ-UHFFFAOYSA-N 0.000 description 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229930192474 thiophene Chemical group 0.000 description 1
- 125000006248 tosyl amino group Chemical group [H]N(*)S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses a method for preparing an alpha-aryl carbonyl compound, which comprises the following steps: r1The substituted iodobenzene diacetate compound is activated by Lewis acid and then reacts with R2Reacting a substituted oxazoline compound in the presence of alkali to obtain the alpha-aryl carbonyl compound; the R is1Selected from H, one or more alkyl groups, one or more haloalkyl groups, alkoxycarbonyl groups, halogen, or polysubstitution of combinations of the foregoing atoms; r2Selected from H, alkyl, substituted alkyl, wherein the substituents are selected from cycloalkyl, halogen, alkoxy, heterocycloalkyl, substituted heterocycloalkyl, aryl, cyano, aryloxy, carbonyl. The method has mild reaction conditions, easy product separation and simple operation.
Description
Technical Field
The invention belongs to the field of organic chemical synthesis, and particularly relates to a novel method for preparing an alpha-aryl carbonyl compound and a product.
Background
Due to the importance of α -arylcarbonyl compounds, extensive research has been undertaken. Are currently important intermediates in the synthesis of many pharmaceutically active molecules. The alpha-arylcarbonyl compounds are mainly used for the development of new drugs in the field of medicine.
Compounds containing an α -arylcarbonyl fragment have important pharmaceutical activities and physiology in the medical field. (J.org.chem.2001,66: 3653; J.Med.chem.1986,29: 523; J.Am.chem.Soc.1985,107: 435; J.Am.chem.Soc.1999,121: 2147.).
To date, several methods for the synthesis of α -arylcarbonyl compounds have been reported in succession.
The cyclic ketone compound can react with diaryl iodonium salt under the action of a metal reagent to prepare an alpha-aryl carbonyl compound (Tetrahedron Lett.1997,38: 5061; Organometallics 1997,16: 3241.). However, this type of reaction requires an equivalent amount of metal catalyst and uses a strong base, which is poor in functional group compatibility.
Carbonyl compounds and haloaromatics can also be used in the synthesis of alpha-arylcarbonyl compounds catalyzed by metallic palladium, nickel or copper (Angew. chem. int. Ed.1997,36: 1740; J.Am. chem.Soc.1997,119: 1110; J.Org. chem.2007,72: 5069; J.chem.Soc.1929, 1870.). However, the method has poor selectivity, narrow substrate range and poor functional group compatibility.
The [3,3] migration rearrangement reaction between aryl sulfoxide and 1, 3-dicarbonyl compound or nitrile compound can also be used for synthesizing alpha-aryl carbonyl compound (J.Am.chem.Soc.2011,133: 8510; J.Am.chem.Soc.2017,139: 4211). However, the method has special substrates and the reaction is sensitive to moisture.
Disclosure of Invention
In order to overcome the defects in the prior art, the invention provides a novel method for preparing an alpha-aryl carbonyl compound, which has the advantages of mild reaction conditions, easy product separation, simple operation and the like.
A method of making an α -arylcarbonyl compound, comprising: r1The substituted iodobenzene diacetate compound is activated by Lewis acid and then reacts with R2Reacting a substituted oxazoline compound in the presence of alkali to obtain the alpha-arylcarbonyl compound;
the R is1Selected from H, one or more alkyl groups, one or more haloalkyl groups, alkoxycarbonyl groups, halogen, or polysubstitution of combinations of the foregoing atoms; r2Selected from H, alkyl, substituted alkyl, wherein the substituents are selected from cycloalkyl, halogen, alkoxy, heterocycloalkyl, substituted heterocycloalkyl, aryl, cyano, aryloxy, carbonyl.
The present invention provides a novel method for preparing an alpha-arylcarbonyl compound by synthesizing the alpha-arylcarbonyl compound through [3,3] migratory rearrangement reaction of iodobenzene diacetate and oxazoline in the presence of an organic solvent.
Preferably, R is1Is selected from H, one or more C1-C3 alkyl, one or more halogenated C1-C3 alkyl, C1-C3 alkoxycarbonyl, halogen or polysubstitution formed by the combination of the atoms; r is2Is selected from H, C1-C10 alkyl and substituted C1-C10 alkyl, wherein the substituent is selected from cyclohexyl, halogen, C1-C3 alkoxy, piperidyl, substituted piperidyl, phenyl, halogen substituted phenyl, cyano, phenoxy, halogen substituted phenoxy, styrene substituted carbonyl and thiophene substituted carbonyl.
As a further preference, the R group1Selected from H, methyl, multiple methyl multiple substitutions, halogenated methyl, multiple halogenated methyl multiple substitutions, methoxycarbonyl, halogen or multiple substitutions consisting of halogen and one or more methyl; when the substituent is a poly-substituted substituent, it may be a meta-substituted substituent or a para-substituted substituent.
As a further preference, the R group2Selected from H, N-butyl, methyl, isopropyl substituted ethyl (substituted at the 1 or 2 position), isobutyl, isopropyl, cyclohexylmethyl, chloropropyl (substituted at the 1, 2, and 3 positions), bromo N-hexyl (optionally substituted at the 1 to 6 positions), I11 alkyl, 6- (p-toluenesulfonyloxy) hexyl, methoxy substituted N-hexyl (optionally substituted at the 1 to 6 positions), N-substituted piperidin-6-yl (such as N-p-toluenesulfonyl substituted) ethyl, 2-p-bromophenylethyl, cyano substituted pentyl, 4-p-chloromethyloxy N-butyl, 1-hepten-7-yl, 2-methoxycarbonylethyl and the like.
As an alternative, the α -arylcarbonyl compound is further hydrolyzed to give the corresponding carboxylic acid compound:
the compounds can be used to synthesize a variety of existing or new compounds. R1、R2The substitution is as described above.
The hydrolysis can be carried out in inorganic acid solution such as sulfuric acid, the reaction solvent can be 1, 4-dioxane, toluene and the like, and the reaction temperature can be 80-120 ℃.
The carboxylic acid compound may be further reduced to obtain a corresponding alcohol compound, or may be reacted with an alcohol compound or an ammonia compound to obtain a corresponding ester compound, amide compound, or the like. The iodine substituted position on the carboxylic acid compound can react with an alkene compound (such as styrene) or an alkyne compound (phenylacetylene) to obtain a corresponding phenylalkene compound (styrene substituted benzene carboxylic acid compound) or phenylalkyne compound (phenylacetylene substituted benzene carboxylic acid compound); or a biphenyl-substituted carboxylic acid compound with phenylboronic acid. Or the combination of the above reaction types is used for preparing the existing medicament or medicament intermediate, or preparing a new medicament or medicament intermediate and the like.
Preferably, the Lewis acid is one or more of trimethylsilyl trifluoromethanesulfonate, triethylsilyl trifluoromethanesulfonate and triisopropylsilyl trifluoromethanesulfonate.
Preferably, the reaction temperature is: -50 ℃ to 30 ℃; more preferably: -40 ℃ to 25 ℃. The reaction is carried out in an organic solvent, wherein the organic solvent is one or a mixture of dichloromethane and acetonitrile.
Preferably, the base used is one or more of 2-methylpyridine, triethylenediamine, triethylamine, diisopropylethylamine and 1, 8-diazabicycloundecen-7-ene.
Preferably, R is1Substituted iodobenzene diacetate compounds and R2The mol ratio of the substituted oxazoline compound is 1: (1-3); the R is1The molar ratio of the substituted iodobenzene diacetate compound to the Lewis acid is 1: (1-3); the R is1The molar ratio of the substituted iodobenzene diacetate compound to the alkali is 1: (1-3). That is, the equivalents of each species in the process are: r1Substituted iodobenzene diacetate 1.0equiv, R2Substituted oxazoline of 1.0 to 3.0equiv, LewisAcid 1.0 to 3.0equiv, base 1.0 to 3.0 equiv.
The specific process of the method comprises the following steps: r was weighed at-40 ℃ in a 100mL reaction flask1Adding solvent into substituted iodobenzene diacetate, adding Lewis acid, stirring, adding R2The substituted oxazoline is taken up, after a suitable time, the reaction progress is followed by thin layer chromatography, and the volume ratio of petroleum ether to ethyl acetate is (3/1) as a developing agent. After the reaction is finished, the reaction materials are decompressed and concentrated, and are separated by column chromatography to obtain the alpha-aryl carbonyl compound.
A compound having the structure shown in the formula:
the R is1Selected from H, one or more alkyl groups, one or more haloalkyl groups, alkoxycarbonyl groups, halogen, or polysubstitution of combinations of the foregoing atoms; r2Selected from H, alkyl, substituted alkyl, wherein the substituents are selected from cycloalkyl, halogen, alkoxy, heterocycloalkyl, substituted heterocycloalkyl, aryl, cyano, aryloxy, carbonyl.
A common structure is as follows:
a compound having the structure shown in the formula:
the R is1Selected from H, one or more alkyl groups, one or more haloalkyl groups, alkoxycarbonyl groups, halogen, or polysubstitution of combinations of the foregoing atoms; r2Selected from alkyl, substituted alkyl, wherein the substituents are selected from cycloalkyl, halogen, alkoxy, heterocycloalkyl, substituted heterocycloalkyl, aryl, cyano, aryloxy, carbonyl.
in the invention, R1Substituted iodobenzene diacetate compounds and R2The substituted oxazoline compound can be directly purchased in the market and can also be prepared by self.
Compared with the prior art, the method has the advantages that the method adopts R1Substituted iodobenzene diacetate and R2Substituted oxazoline [3,3]]The migration rearrangement reaction for synthesizing the alpha-aryl carbonyl compound has the advantages that:
the method has mild reaction conditions, good selectivity, easy product separation and simple operation;
the raw materials used in the method are cheap and easy to obtain, thus avoiding the catalyst which is used in the traditional method and is difficult to prepare and purchase, and the reaction condition is harsh;
the alpha-aryl carbonyl compound with stable chemical property can be prepared by the [3,3] migration rearrangement reaction of iodobenzene diacetate and oxazoline, and a new reaction strategy is provided for the synthesis of the compound.
Detailed Description
The following presents specific embodiments of the novel process for the preparation of α -arylcarbonyl compounds provided by the present invention, and a number of specific embodiments are provided. It should be noted that the practice of the present invention is not limited to the following practical examples.
Examples R1The substituted iodobenzene diacetate is prepared from a commercially available product R2The substituted oxazoline part is commercially available, and the preparation method of the partial compound comprises the following steps:
2-pentyl-4, 5-dihydrooxazole (4 a):
to 2-chloroethylamino hydrochloride (10.21g,88mmol) and Et at 0 deg.C3Hexanoyl chloride (11.2mL,80mmol) was added dropwise to a solution of N (28mL,200mmol) in DCM (267 mL). System liquid literThe mixture is warmed to room temperature and stirred for 3 hours. Quench the system with water, extract with DCM, Na2SO4Drying, concentration, recrystallization of the concentrate (DCM and PE) gave 9.67g of N- (2-chloroethyl) hexanamide as a white solid in 68% yield. (Rf: 0.48, eluent: PE/EtOAc: 1/1).
To a solution of N- (2-chloroethyl) hexanamide (9.67g,54mmol) in MeOH (360mL) was added NaOH (3.02g,76 mmol). Reflux overnight, concentrate, sat NaHCO3Diluting with water solution, and extracting with DCM. The organic layers were combined and Na2SO4Drying and concentrating. The residue was purified by column chromatography to give compound 4a as a pale yellow oil: 2-pentyl-4, 5-dihydrooxazole, 5.95g, yield 78%. (Rf 0.20, eluent: PE/EtOAc 3/1).1H NMR(600MHz,CDCl3):δ4.18(t,J=9.5Hz,2H),3.78(t,J=9.5Hz,2H),2.22(t,J=7.7Hz,2H),1.66–1.54(m,2H),1.35–1.24(m,4H),0.86(t,J=6.6Hz,3H)。
2- (4-methylpentyl) -4, 5-dihydrooxazole (4 e):
to a solution of 2-methyl-4, 5-dihydrooxazole (1.70g,20mmol) in THF (67mL) was added n-BuLi (2.5M,8.8mL) dropwise at-78 ℃. Stirring was carried out for 3h and a solution of 1-bromo-3-methylbutane (3.02g,20mmol) in THF (14.0mL) was added dropwise at-78 deg.C. Stirring is continued for 1h, and the system liquid is warmed to room temperature and stirred overnight. Adding water, extracting with DCM, mixing organic layers, and adding Na2SO4Drying, concentration and column chromatography of the residue afforded compound 4e, 2.30g, 74% yield. (Rf 0.25, eluent: PE/EtOAc 2/1).1H NMR(600MHz,CDCl3):δ4.21(t,J=9.5Hz,2H),3.81(t,J=9.5Hz,2H),2.26–2.21(m,2H),1.65–1.58(m,2H),1.58–1.51(m,1H),1.24–1.18(m,2H),0.87(d,J=6.6Hz,6H)。
2- (2- (1-Ts-piperidin-4-yl) ethyl) -4, 5-dihydrooxazole (4 l):
according to the preparation of compound 4e, using 15mmol of the corresponding bromoalkyl group, the compound (4l) was obtained as a white solid m.p.134-136 ℃ in 2.37g, 47% yield. (Rf 0.33, eluent: PE/EtOAc 1/2).1H NMR(600MHz,CDCl3):δ7.60(d,J=8.2Hz,2H),7.29(d,J=8.0Hz,2H),4.16(t,J=9.5Hz,2H),3.78–3.68(m,4H),2.40(s,3H),2.24–2.15(m,4H),1.75–1.67(m,2H),1.57–1.49(m,2H),1.31–1.15(m,3H)。
2- (7-methoxyheptyl) -4, 5-dihydrooxazole (4m):
following the preparation of compound 4e, using 8mmol of the corresponding bromoalkyl group, compound 4m was obtained as a yellow oil: 924.8mg, 58% yield (Rf 0.21, eluent: PE/EtOAc 1/1).1H NMR(600MHz,CDCl3):δ4.20(t,J=9.5Hz,2H),3.80(t,J=9.5Hz,2H),3.34(t,J=6.6Hz,2H),3.31(s,3H),2.25(t,J=7.7Hz,2H),1.65–1.58(m,2H),1.58–1.51(m,2H),1.38–1.28(m,6H)。
Other substrates may be prepared by similar methods as described above, or may be commercially available.
The preparation method comprises the following steps:
vacuumizing a 100ml reaction bottle, replacing nitrogen for three times, and adding R under the protection of nitrogen1Substituted iodobenzene diacetate (1.0mmol,1.0eq) and anhydrous DCM (10mL,0.1M) were placed at-40 ℃ and trimethylsilyl trifluoromethanesulfonate (2.0mmol,2.0eq.) was added after 10 minutes of reaction and R was added2The substituted oxazoline (2.0mmol,2.0eq.) was replaced and after a further 10 minutes, 2-methylpyridine (2.0mmol,2.0eq.) was added. After 24 hours the progress of the reaction was followed by thin layer chromatography using a volume ratio petroleum ether/ethyl acetate of 3/1 as developing agent, the reaction was monitored to be complete, treated with saturated sodium bicarbonate, extracted with DCM, the organic phases were combined and Na was added2SO4Drying, concentrating the organic phase under reduced pressure, and separating by column chromatography to obtain the product.
Example 1
R1Taking H, R2Taking n-butyl, 212.8mg of compound 1 was obtained as a yellow liquid in a yield of 62% according to the above-mentioned method.
1H NMR(600MHz,CDCl3):δ7.83(d,J=7.9Hz,1H),7.38–7.34(m,1H),7.30(t,J=7.5Hz,1H),6.95–6.88(m,1H),4.26–4.19(m,1H),4.19–4.13(m,1H),4.01(t,J=7.5Hz,1H),3.85(t,J=9.5Hz,2H),2.07–1.97(m,1H),1.83–1.74(m,1H),1.39–1.29(m,3H),1.25–1.18(m,1H),0.86(t,J=7.2Hz,3H).
13C NMR(151MHz,CDCl3):δ169.1,143.2,139.7,128.8,128.7,127.9,101.8,67.4,54.4,48.9,34.0,29.6,22.7,14.0.
IR(neat):2954,2929,2871,1659,1583,1561,1460,1435,1171,1108,732.
HRMS(ESI-TOF):calculated for[C14H19INO(M+H+)]:344.0506,found:344.0508.
Example 2
R1Taking H, R2By the same procedure, 225.0mg of Compound 2 was obtained as a yellow liquid in a yield of 63% in the same manner as described above.
1H NMR(600MHz,CDCl3):δ7.86–7.82(m,1H),7.39–7.35(m,1H),7.33–7.29(m,1H),6.95–6.90(m,1H),4.26–4.14(m,2H),3.99(t,J=7.5Hz,1H),3.90–3.80(m,2H),2.06–1.98(m,1H),1.84–1.76(m,1H),1.59–1.51(m,1H),1.32–1.23(m,1H),1.14–1.06(m,1H),0.88–0.83(m,6H).
13C NMR(151MHz,CDCl3):δ169.2,143.3,139.8,128.8,128.7,128.0,101.9,67.5,54.5,49.2,36.5,32.2,28.1,22.7,22.6.
IR(neat):2952,2901,2869,1660,1465,1435,1383,1365,1171,732.
HRMS(ESI-TOF):calculated for[C15H21INO(M+H+)]:358.0662,found:358.0662.
Example 3
R1Taking H, R2The same procedure as described above gave 210.8mg of Compound 3 as a white solid, in 55% yield, of cyclohexylmethyl group. 1H NMR (600MHz, CDCl3): delta 7.88-7.80 (m,1H), 7.41-7.37 (m,1H), 7.33-7.28 (m,1H), 6.96-6.89 (m,1H), 4.26-4.20 (m,1H), 4.19-4.12 (m,2H), 3.89-3.79 (m,2H), 1.96-1.89 (m,1H), 1.84-1.74 (m,2H), 1.70-1.58 (m,4H), 1.28-1.12 (m,4H), 1.00-0.89 (m,2H).
13C NMR(151MHz,CDCl3):δ169.3,143.6,139.9,128.8,128.7,128.1,101.6,67.4,54.5,46.3,42.0,35.3,33.7,33.4,26.6,26.3,26.2.
IR(neat):2921,2886,2849,2836,1665,1464,1446,1180,765.
HRMS(ESI-TOF):calculated for[C17H23INO(M+H+)]:384.0819,found:384.0813.
Example 4
R1Taking H, R2Using the same procedure, 196.3mg of compound 4 was obtained as a yellow liquid in a yield of 60%. 1H NMR (600MHz, CDCl3): δ 7.85-7.80 (m,1H), 7.35-7.32 (m,1H), 7.32-7.28 (m,1H), 6.96-6.87 (m,1H), 4.25-4.19 (m,1H), 4.19-4.12 (m,1H),4.03(t, J ═ 7.3Hz,1H),3.84(t, J ═ 9.7Hz,2H),3.51(t, J ═ 6.5Hz,2H), 2.20-2.12 (m,1H), 1.98-1.84 (m,2H), 1.76-1.68 (m,1H).
13C NMR(151MHz,CDCl3):δ168.5,142.5,139.8,129.0,128.8,127.8,101.6,67.5,54.4,48.2,44.7,31.5,30.4.
IR(neat):2954,2879,1659,1583,1562,1464,1434,1010,750,728.
HRMS(ESI-TOF):calculated for[C13H16ClINO(M+H+)]:363.9960,found:363.9958.
Example 5
R1Taking H, R2By the same procedure, 240.8mg of compound 5 was obtained as a yellow liquid in a yield of 60% using 6-methoxyhexyl.
1H NMR(600MHz,CDCl3):δ7.85–7.81(m,1H),7.37–7.33(m,1H),7.32–7.28(m,1H),6.94–6.90(m,1H),4.25–4.19(m,1H),4.19–4.13(m,1H),4.01(t,J=7.5Hz,1H),3.88–3.81(m,2H),3.34–3.31(m,2H),3.30(s,3H),2.06–1.98(m,1H),1.82–1.74(m,1H),1.55–1.50(m,2H),1.39–1.25(m,6H).
13C NMR(151MHz,CDCl3):δ169.1,143.2,139.8,128.8,128.7,128.0,101.8,73.0,67.4,58.6,54.5,48.9,34.2,29.7,29.4,27.4,26.0.
IR(neat):2928,2855,1660,1463,1435,1115,1010,982,729.
HRMS(ESI-TOF):calculated for[C17H25INO2(M+H+)]:402.0924,found:402.0912。
Example 6
R1Taking H, R2Taking N-Ts piperidin-1-yl-methyl group, 323.0mg of compound 6 as a yellow liquid was obtained in the same manner, and the yield was 60%.1H NMR(600MHz,CDCl3):δ7.60–7.72(m,1H),7.58–7.52(m,2H),7.29–7.26(m,1H),7.26–7.21(m,3H),6.88–6.82(m,1H),4.16–4.10(m,1H),4.09–4.00(m,2H),3.75(t,J=9.5Hz,2H),3.68(d,J=11.5Hz,2H),2.35(s,3H),2.17–2.09(m,2H),1.94–1.87(m,1H),1.81(d,J=12.7Hz,1H),1.73(d,J=12.8Hz,1H),1.64–1.58(m,1H),1.38–1.23(m,2H),1.21–1.16(m,1H).
13C NMR(151MHz,CDCl3):δ168.6,143.4,142.7,139.8,133.1,129.6,129.0,128.8,127.8,127.7,101.4,67.4,54.3,46.3,46.2,46.0,40.4,32.7,31.7,31.4,21.5.
IR(neat):2917,2843,1658,1596,1435,1194,1144,1094,814.
HRMS(ESI-TOF):calculated for[C23H28IN2O3S(M+H+)]:539.0860,found:539.0830.
Example 7
R1Taking methyl (I-substituted para), R2Taking n-butyl, 235.8mg of Compound 7 was obtained as a yellow liquid in a yield of 66% by the same method.
1H NMR(600MHz,CDCl3):δ7.69(d,J=8.1Hz,1H),7.17–7.14(m,1H),6.78–6.73(m,1H),4.27–4.14(m,2H),3.97(t,J=7.5Hz,1H),3.90–3.82(m,2H),2.28(s,3H),2.07–1.96(m,1H),1.82–1.73(m,1H),1.39–1.30(m,3H),1.25–1.19(m,1H),0.87(t,J=7.2Hz,3H).
13C NMR(151MHz,CDCl3):δ169.4,142.9,139.4,138.7,130.0,128.6,97.8,67.5,54.4,48.7,34.1,29.6,22.8,21.2,14.1.
IR(neat):2954,2928,2871,1159,1466,1171,1008,984,806,731.
HRMS(ESI-TOF):calculated for[C15H21INO(M+H+)]:358.0662,found:358.0656.
Example 8
R1Taking Cl (I substituted pairBit), R2Taking n-butyl, 151.1mg of compound 8 as a yellow liquid was obtained in the same manner, and the yield was 40%.
1H NMR(400MHz,CDCl3):δ7.73(d,J=8.4Hz,1H),7.35(d,J=2.5Hz,1H),6.94–6.89(m,1H),4.27–4.15(m,2H),3.96(t,J=7.5Hz,1H),3.86(t,J=9.6Hz,2H),2.05–1.96(m,1H),1.78–1.71(m,1H),1.37–1.28(m,3H),1.25–1.19(m,1H),0.87(t,J=7.2Hz,3H).
13C NMR(101MHz,CDCl3):δ168.4,145.2,140.6,135.0,129.0,128.1,98.7,67.5,54.5,48.9,34.0,29.5,22.6,14.0.
IR(neat):2953,2927,2870,1656,1575,1478,1455,1193,1105,732.
HRMS(ESI-TOF):calculated for[C14H18ClINO(M+H+)]:378.0116,found:378.0104.
Example 9
R1Taking H, R2Taking the methyl group, 225.8mg of a yellow liquid compound, 9, 2- (1- (2-iodophenyl) ethyl) -4, 5-dihydrooxazole, 75% yield, (Rf ═ 0.20, element: PE/EtOAc ═ 3/1) was obtained in the same manner.
1H NMR(600MHz,CDCl3):δ7.83(d,J=7.9Hz,1H),7.30(d,J=4.0Hz,2H),6.96–6.88(m,1H),4.28–4.15(m,2H),4.13–4.04(m,1H),3.92–3.81(m,2H),1.48(d,J=7.1Hz,3H).
13C NMR(151MHz,CDCl3):δ169.8,144.3,139.8,128.80,128.79,127.5,100.8,67.7,54.5,43.7,19.2.
IR(neat):2975,2932,2901,2878,1659,1584,1466,1433,1181,1118,747.
HRMS(ESI-TOF):calculated for[C11H13INO(M+H+)]:302.0036,found:302.0030。
Example 10
R1Taking H, R2Taking H, 89mg of yellow liquid compound 10 can be obtained by the same method: 2- (2-iodophenyl) -4, 5-dihydrooxazole, 31% yield (Rf ═ 0.33, eluent: PE/EtOAc ═ 1/1).
1H NMR(600MHz,CDCl3):δ7.86–7.81(m,1H),7.36–7.28(m,2H),6.97–6.92(m,1H),4.26(t,J=9.5Hz,2H),3.84(t,J=9.5Hz,2H),3.75(s,2H).
13C NMR(151MHz,CDCl3):δ166.0,139.7,138.6,130.2,128.9,128.5,100.9,67.8,54.7,39.8.
IR(neat):2902,2878,1662,1585,1563,1464,1206,1107,733.
HRMS(ESI-TOF):calculated for[C10H11INO(M+H+)]:287.9880,found:287.9879。
Preparation of carboxylic acid:
obtaining a corresponding carboxylic acid compound from the compound 1-10 according to the following method:
to a 25mL reaction tube was added compound I (1.0mmol), 4M H2SO4(2.0mL) and 1, 4-dioxane (2.0mL), followed by reaction at 100 ℃ for 15 h. After the reaction was completed, it was cooled to room temperature, and 2M NaOH was added thereto to make it alkaline, followed by concentration under reduced pressure. The residue is acidified with 1M HCl and extracted with dichloromethane, and the organic phase is freed from anhydrous Na2SO4Drying and concentrating under reduced pressure to obtain the product, which does not need further purification.
Claims (3)
1. A method of preparing an α -arylcarbonyl compound, comprising: r1The substituted iodobenzene diacetate compound is activated by Lewis acid and then reacts with R2Substituted oxazoline compounds in the presence of a baseReacting under the condition to obtain the alpha-aryl carbonyl compound;
the R is1Is selected from H, one or more C1-C3 alkyl, one or more halogenated C1-C3 alkyl, halogen or polysubstitution formed by the combination of the substituents;
R2selected from H, C1-C10 alkyl and substituted C1-C10 alkyl, wherein the substituent is selected from cyclohexyl, halogen, C1-C3 alkoxy and piperidyl;
the Lewis acid is one or more of trimethylsilyl trifluoromethanesulfonate, triethylsilyl trifluoromethanesulfonate and triisopropylsilyl trifluoromethanesulfonate;
the reaction temperature is as follows: -50 ℃ to 30 ℃; the reaction is carried out in an organic solvent, wherein the organic solvent is one or a mixture of dichloromethane and acetonitrile;
the base used is one or more of 2-methylpyridine, triethylenediamine, triethylamine, diisopropylethylamine and 1, 8-diazabicycloundecen-7-ene.
3. the method for producing an α -arylcarbonyl compound according to claim 1, wherein R is1Substituted iodobenzene diacetate compounds and R2The mol ratio of the substituted oxazoline compound is 1: (1-3); the R is1The molar ratio of the substituted iodobenzene diacetate compound to the Lewis acid is 1: (1-3); the R is1Iodobenzene reaction of substituted diacetic acidThe molar ratio of compound to base is 1: (1-3).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010062704.7A CN113135869B (en) | 2020-01-20 | 2020-01-20 | Method for preparing alpha-aryl carbonyl compound and product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010062704.7A CN113135869B (en) | 2020-01-20 | 2020-01-20 | Method for preparing alpha-aryl carbonyl compound and product |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113135869A CN113135869A (en) | 2021-07-20 |
CN113135869B true CN113135869B (en) | 2022-06-10 |
Family
ID=76809246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010062704.7A Active CN113135869B (en) | 2020-01-20 | 2020-01-20 | Method for preparing alpha-aryl carbonyl compound and product |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113135869B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114773285A (en) * | 2022-03-25 | 2022-07-22 | 大连理工大学 | Efficient preparation method of alpha-amino oxazoline compound |
CN114671822A (en) * | 2022-03-25 | 2022-06-28 | 浙江师范大学 | Method for preparing alpha-heteroatom functionalized 2-oxazoline and compound |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10266503B1 (en) * | 2016-05-24 | 2019-04-23 | The Board Of Trustees Of The University Of Illinois | Sulfoxide ligand metal catalyzed oxidation of olefins |
-
2020
- 2020-01-20 CN CN202010062704.7A patent/CN113135869B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10266503B1 (en) * | 2016-05-24 | 2019-04-23 | The Board Of Trustees Of The University Of Illinois | Sulfoxide ligand metal catalyzed oxidation of olefins |
Non-Patent Citations (2)
Title |
---|
A Direct Arylation-Cyclisation Reaction for the Construction of Medium-Sized Rings;Daniel Whitaker et al.;《Chem. Eur. J.》;20170907;第23卷;第12763-12766页 * |
Iridium-Catalyzed Highly Enantioselective Hydrogenation of the C=C Bond of α, β-Unsaturated Ketones;Wei-Jing Lu et al.;《Angew. Chem. Int. Ed.》;20081119;第47卷;第10133-10136页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113135869A (en) | 2021-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wilson et al. | Bis (2-diphenylphosphinoethyl) amine. A flexible synthesis of functionalized chelating diphosphines | |
CN113135869B (en) | Method for preparing alpha-aryl carbonyl compound and product | |
CN107473982B (en) | Terminal substituted homoallylamine derivative and preparation method and application thereof | |
CN110937985B (en) | Synthesis method of paradol | |
CN109912492B (en) | Synthetic method of 3-benzylidene isoindoline-1-one derivative | |
JPWO2015115519A1 (en) | Bipyridyl compounds | |
CN114773285A (en) | Efficient preparation method of alpha-amino oxazoline compound | |
CA2560964C (en) | Synthesis of pyrrole-2-carbonitriles | |
CN111499542B (en) | Preparation method of cyclic ketene compound containing alpha-cyano substituted quaternary carbon center | |
JP2009046452A (en) | Phosphoramidite ligand and method for producing allylamine by using the same | |
CN115054599A (en) | Application of 2-aminoindole compounds in antitumor drugs | |
CN114989178A (en) | Spiro [ beta-lactam-3, 3' -oxindole ] derivative and preparation method and application thereof | |
CN114907404A (en) | 5- (2- (disubstituted phosphino) phenyl) -1-alkyl-1H-pyrazolylphosphine ligand and preparation method and application thereof | |
CN111187176B (en) | Method for preparing N-vinyl amide compound under catalysis of copper salt | |
CN113135870B (en) | Method for preparing chiral alpha-aryl carbonyl compound and product | |
FR2879601A1 (en) | New phenyl boronic acid compounds are useful for the synthesis of drugs or treatment and/or prevention of pathological conditions | |
KR101554539B1 (en) | Development of Method for Amide Bond Formation via Metal-Free Aerobic Oxidative Amination of Aldehydes | |
US10889599B2 (en) | 1,1-diborylalkyl-1-metal compounds, preparation method thereof, and their applications toward synthesis of 1,1-diboronate ester compounds | |
JP4759722B2 (en) | Process for producing aromatic carboxylic acid ester having a substituent | |
CN111732545B (en) | 2, 3-dihydrospiro [ imidazole-4, 1 ′ -indene]Compounds and preparation method thereof | |
CN110294772B (en) | 2-alkyl silicon-benzamide compound and synthesis method thereof | |
KR100968576B1 (en) | Process of preparing 2-acyl-3-amino-2-alkenoate | |
CN110003062B (en) | N-phenyl-N-p-toluenesulfonyl difluoroacetamide and application thereof | |
JP3918468B2 (en) | 3,3-bis (alkoxycarbonyl-methylthio) propionitrile and process for producing the same | |
CN116444370A (en) | Preparation method of alpha, beta-unsaturated carboxylic acid derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |